{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:09:59Z","timestamp":1790975399838,"version":"4.1.0"},"reference-count":64,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1097\/fjc.0b013e31818eee5f","type":"journal-article","created":{"date-parts":[[2008,12,15]],"date-time":"2008-12-15T03:13:53Z","timestamp":1229310833000},"page":"475-484","source":"Crossref","is-referenced-by-count":19,"title":["Aspirin Resistance: Focus on Clinical Endpoints"],"prefix":"10.1097","volume":"52","author":[{"given":"Gabriella","family":"Pusch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gergely","family":"Feher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Kotai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antal","family":"Tibold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Gasztonyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Feher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elod","family":"Papp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geza","family":"Lupkovics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laszlo","family":"Szapary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210208","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomized trials of antiplatelet therapy. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients.","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"R2-1-20210208","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients.","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"R3-1-20210208","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1517\/14656566.6.12.2027","article-title":"Resistance to antiplatelet drugs: current status and future research.","volume":"6","author":"Tantry","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"R4-1-20210208","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0140-6736(06)68040-9","article-title":"Aspirin resistance.","volume":"367","author":"Hankey","year":"2006","journal-title":"Lancet"},{"key":"R5-1-20210208","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/eurheartj\/ehm226","article-title":"A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease.","volume":"28","author":"Lordkipanidze","year":"2007","journal-title":"Eur Heart J"},{"key":"R6-1-20210208","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1161\/CIRCULATIONAHA.106.675587","article-title":"Evaluation of dose-related effects of aspirin on platelet function. results from the Aspirin-Induced Platelet Effect (ASPECT) study.","volume":"115","author":"Gurbel","year":"2007","journal-title":"Circulation"},{"key":"R7-1-20210208","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1538-7836.2005.01351.x","article-title":"Aspirin resistance: position paper of the Working Group on Aspirin Resistance, Platelet Physiology Subcommittee of the Scientific and Standardization Committee, International Society on Thromb Haemost.","volume":"3","author":"Michelson","year":"2005","journal-title":"J Thromb Haemost"},{"key":"R8-1-20210208","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1001\/archinte.167.15.1593","article-title":"Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis.","volume":"167","author":"Snoep","year":"2007","journal-title":"Arch Intern Med"},{"key":"R9-1-20210208","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/bmj.39430.529549.BE","article-title":"Aspirin resistance and risk of cardiovascular morbidity: systematic review and meta-analysis.","volume":"336","author":"Krasopoulos","year":"2008","journal-title":"BMJ"},{"issue":"Suppl 1","key":"R10-1-20210208","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1538-7836.2007.02498.x","article-title":"Resistance to antiplatelet drugs: molecular mechanisms and laboratory detection.","volume":"5","author":"Cattaneo","year":"2007","journal-title":"J Thromb Haemost"},{"key":"R11-1-20210208","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/nm1102-1227","article-title":"Platelets in atherothrombosis.","volume":"8","author":"Ruggeri","year":"2002","journal-title":"Nat Med"},{"key":"R12-1-20210208","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1161\/01.ATV.0000145980.39477.a9","article-title":"Aspirin and clopidogrel. Efficacy, safety and the issue of drug resistance.","volume":"24","author":"Cattaneo","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R13-1-20210208","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2002-12-3882","article-title":"Platelet-collagen interaction: is GPVI the central receptor?","volume":"102","author":"Nieswandt","year":"2003","journal-title":"Blood"},{"key":"R14-1-20210208","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.cardiores.2003.11.036","article-title":"Role of platelets in coronary thrombosis and reperfusion of ischaemic myocardium.","volume":"61","author":"Gawaz","year":"2004","journal-title":"Cardiovasc Res"},{"key":"R15-1-20210208","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/15216540310001649831","article-title":"Platelet interactions in thrombosis.","volume":"56","author":"Andrews","year":"2004","journal-title":"IUBMB Life"},{"key":"R17-1-20210208","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1161\/01.CIR.0000013777.21160.07","article-title":"Aspirin resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke or cardiovascular death in patients at risk of high for cardiovascular event.","volume":"105","author":"Eikelboom","year":"2002","journal-title":"Circulation"},{"key":"R18-1-20210208","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1161\/01.STR.0000117097.76953.A6","article-title":"Serial urinary 11-dehydrothromboxane B2, aspirin dose, and vascular events in blacks after recent cerebral infarction.","volume":"35","author":"Bruno","year":"2004","journal-title":"Stroke"},{"key":"R19-1-20210208","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.amjcard.2006.07.058","article-title":"Partial inhibition of platelet thromboxane A2 synthesis by aspirin is associated with myonecrosis in patients with ST-segment elevation myocardial infarction.","volume":"99","author":"Valles","year":"2007","journal-title":"Am J Cardiol"},{"key":"R20-1-20210208","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0049-3848(93)90164-J","article-title":"Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients.","volume":"71","author":"Grotemeyer","year":"1993","journal-title":"Thromb Res"},{"key":"R21-1-20210208","first-page":"1385","article-title":"Results of the BRAT study-a pilot study investigating the possible significance of ASA nonresponsiveness on the benefits and risks of ASA on thrombosis in patients undergoing coronary artery bypass surgery.","volume":"16","author":"Buchanan","year":"2000","journal-title":"Can J Cardiol"},{"key":"R22-1-20210208","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0735-1097(02)03014-0","article-title":"A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease.","volume":"41","author":"Gum","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R23-1-20210208","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ahj.2003.07.011","article-title":"Lack of aspirin effect: aspirin resistance or resistance to taking aspirin?","volume":"147","author":"Cotter","year":"2004","journal-title":"Am Heart J"},{"key":"R24-1-20210208","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1600-0404.2005.00419.x","article-title":"Aspirin resistance in secondary stroke prevention.","volume":"113","author":"Berrouschot","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"R25-1-20210208","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/09537100310001644006","article-title":"Prospective evaluation of the relationship between platelet-leukocyte conjugate formation and recurrent myocardial ischemia in patients with acute coronary syndromes.","volume":"15","author":"Faraday","year":"2004","journal-title":"Platelets"},{"key":"R26-1-20210208","first-page":"695","article-title":"Study on the relationship between aspirin resistance and incidence of myonecrosis after non-emergent percutaneous coronary intervention.","volume":"33","author":"Zhang","year":"2005","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"R27-1-20210208","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.jacc.2005.05.090","article-title":"Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation.","volume":"46","author":"Tantry","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R28-1-20210208","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1160\/TH05-10-0649","article-title":"Biological efficacy of low against medium dose aspirin regimen after coronary surgery: analysis of platelet function.","volume":"95","author":"Cornelissen","year":"2006","journal-title":"Thromb Haemost"},{"key":"R29-1-20210208","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/j.1538-7836.2006.01958.x","article-title":"Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients.","volume":"4","author":"Ohmori","year":"2006","journal-title":"J Thromb Haemost"},{"key":"R30-1-20210208","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ejim.2006.01.006","article-title":"Aspirin resistance measured by cationic propyl gallate platelet aggregometry and recurrent cardiovascular events during 4 years of follow-up.","volume":"17","author":"Stejskal","year":"2006","journal-title":"Eur J Intern Med"},{"key":"R31-1-20210208","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jacc.2005.08.058","article-title":"Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance.","volume":"47","author":"Lev","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R33-1-20210208","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/107602969600200404","article-title":"Characterisation of an in vitro platelet function analyser, PFA-100TM.","volume":"2","author":"Kundu","year":"1996","journal-title":"Clin Appl Thromb Hemost"},{"key":"R34-1-20210208","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.amjcard.2006.05.041","article-title":"Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events.","volume":"98","author":"Marcucci","year":"2006","journal-title":"Am J Cardiol"},{"key":"R35-1-20210208","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.thromres.2006.04.005","article-title":"Prevalence of aspirin resistance in patients with an evolving acute myocardial infarction.","volume":"119","author":"Poulsen","year":"2007","journal-title":"Thromb Res"},{"key":"R36-1-20210208","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/MBC.0b013e328040c115","article-title":"Clinical relevance of aspirin resistance in patients with stable coronary artery disease: a prospective follow-up study (PROSPECTAR).","volume":"18","author":"Pamukcu","year":"2007","journal-title":"Blood Coag Fibr"},{"key":"R37-1-20210208","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.thromres.2006.10.022","article-title":"Variation and importance of aspirin resistance in patients with known cardiovascular disease.","volume":"120","author":"Poulsen","year":"2007","journal-title":"Thromb Res"},{"key":"R38-1-20210208","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0049-3848(02)00405-X","article-title":"Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease.","volume":"108","author":"Andersen","year":"2002","journal-title":"Thromb Res"},{"key":"R39-1-20210208","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.thromres.2004.07.004","article-title":"Late saphenous vein graft occlusion in patients with coronary bypass: possible role of aspirin resistance.","volume":"115","author":"Yilmaz","year":"2005","journal-title":"Thromb Res"},{"key":"R40-1-20210208","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00415-003-0954-y","article-title":"Aspirin non-responder status in patients with recurrent cerebral ischemic attacks.","volume":"250","author":"Grundmann","year":"2003","journal-title":"J Neurol"},{"key":"R42-1-20210208","first-page":"40","article-title":"Persistent platelet activation is related to very early cardiovascular events in patients with acute coronary syndromes.","volume":"65","author":"Malek","year":"2007","journal-title":"Kardiol Pol"},{"key":"R43-1-20210208","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11239-006-8952-4","article-title":"The role of aspirin resistance on outcome in patients with acute coronary syndrome and the effect of clopidogrel therapy in the prevention of major cardiovascular events.","volume":"22","author":"Pamukcu","year":"2006","journal-title":"J Thromb Thrombol"},{"key":"R44-1-20210208","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ahj.2004.10.007","article-title":"The role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosis.","volume":"149","author":"Pamukcu","year":"2005","journal-title":"Am Heart J"},{"key":"R45-1-20210208","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0828-282X(07)70744-4","article-title":"The effect of acetylsalicylic acid resistance on prognosis of patients who have developed acute coronary syndrome during acetylsalicylic acid therapy.","volume":"23","author":"Hobikoglu","year":"2007","journal-title":"Can J Cardiol"},{"key":"R46-1-20210208","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1477-9560-3-10","article-title":"Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels.","volume":"3","author":"Borna","year":"2005","journal-title":"Thromb J"},{"key":"R47-1-20210208","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1620\/tjem.207.59","article-title":"High frequency of aspirin resistance in patients with acute coronary syndrome.","volume":"207","author":"Hobikoglu","year":"2005","journal-title":"Tohoku J Exp Med"},{"key":"R48-1-20210208","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11239-007-0045-5","article-title":"Abnormal PFA-100 closure time is associated with increased platelet aggregation in patients presenting with chest pain.","volume":"25","author":"Atiemo","year":"2008","journal-title":"J Thromb Thrombol"},{"key":"R49-1-20210208","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jtcvs.2005.08.058","article-title":"Endothelial injury and acquired aspirin resistance as promoters of regional thrombin formation and early vein graft failure after coronary artery bypass grafting.","volume":"131","author":"Poston","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R50-1-20210208","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1055\/s-0038-1657677","article-title":"Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty.","volume":"78","author":"Mueller","year":"1997","journal-title":"Thromb Haemost"},{"key":"R51-1-20210208","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.amjcard.2007.01.023","article-title":"Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.","volume":"99","author":"Buch","year":"2007","journal-title":"Am J Cardiol"},{"key":"R52-1-20210208","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.jacc.2003.12.034","article-title":"Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment.","volume":"43","author":"Chen","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R53-1-20210208","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/09537100701771736","article-title":"Lack of reproducibility of assessment of aspirin responsiveness by optical aggregometry and two platelet function tests.","volume":"19","author":"Harrison","year":"2008","journal-title":"Platelets"},{"key":"R54-1-20210208","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.thromres.2007.04.010","article-title":"Screening for aspirin resistance in stable coronary artery patients by three different tests.","volume":"121","author":"Chakroun","year":"2007","journal-title":"Thromb Res"},{"key":"R56-1-20210208","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1742-1241.2006.01063.x","article-title":"Platelet inhibition beyond conventional antiplatelet agents: expanding role of angiotensin receptor blockers, statins and selective serotonin reuptake inhibitors.","volume":"60","author":"Malinin","year":"2006","journal-title":"Int J Clin Pract"},{"key":"R57-1-20210208","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijcard.2006.09.014","article-title":"Clopidogrel resistance: role of body mass and concomitant medications.","volume":"120","author":"Feher","year":"2007","journal-title":"Int J Cardiol"},{"key":"R58-1-20210208","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2165\/00002512-200623070-00002","article-title":"Aspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variables.","volume":"23","author":"Feher","year":"2006","journal-title":"Drugs Aging"},{"key":"R59-1-20210208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.fjc.0000238592.67191.ab","article-title":"Resveratrol inhibits aggregation of platelets from high-risk cardiac patients with aspirin resistance.","volume":"48","author":"Stef","year":"2006","journal-title":"J Cardiovasc Pharmacol"},{"key":"R60-1-20210208","first-page":"428","article-title":"Inhibition of NAD(P)H oxidase attenuates aggregation of platelets from high-risk cardiac patients with aspirin resistance.","volume":"59","author":"Stef","year":"2007","journal-title":"Pharmacol Rep"},{"issue":"Suppl 1","key":"R61-1-20210208","doi-asserted-by":"crossref","first-page":"39S","DOI":"10.1111\/j.1537-2995.2007.01575.x","article-title":"Perioperative management of aspirin resistance after off-pump coronary artery bypass grafting: possible role for aprotinin.","volume":"48","author":"Poston","year":"2008","journal-title":"Transfusion"},{"key":"R62-1-20210208","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0049-3848(02)00210-4","article-title":"Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate.","volume":"107","author":"Macchi","year":"2002","journal-title":"Thromb Res"},{"key":"R63-1-20210208","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1111\/j.1538-7836.2005.01640.x","article-title":"Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial.","volume":"3","author":"Eikelboom","year":"2005","journal-title":"J Thromb Haemost"},{"key":"R64-1-20210208","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1160\/TH06-12-0722","article-title":"The additive antiplatelet action of clopidogrel in patients with coronary artery disease treated with aspirin.","volume":"98","author":"Dropinski","year":"2007","journal-title":"Thromb Haemost"},{"key":"R65-1-20210208","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1093\/eurheartj\/ehl334","article-title":"A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease.","volume":"27","author":"Biondi-Zoccai","year":"2006","journal-title":"Eur Heart J"},{"key":"R66-1-20210208","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ehj.2003.10.013","article-title":"Cardiology: Expert consensus document on the use of antiplatelet agents.","volume":"25","year":"2004","journal-title":"Eur Heart J"},{"key":"R67-1-20210208","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1538-7836.2005.01351.x","article-title":"Aspirin resistance: position paper of the Working Group on Aspirin Resistance.","volume":"3","author":"Michelson","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"Suppl 1","key":"R68-1-20210208","doi-asserted-by":"crossref","first-page":"I10","DOI":"10.1002\/clc.20361","article-title":"Assessing the current role of platelet function testing.","volume":"31","author":"Braunwald","year":"2008","journal-title":"Clin Cardiol"}],"container-title":["Journal of Cardiovascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FJC.0b013e31818eee5f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:28:54Z","timestamp":1786037334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005344-200812000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/fjc.0b013e31818eee5f","relation":{},"ISSN":["0160-2446"],"issn-type":[{"value":"0160-2446","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}